More
Vaccines – More Autism
· In 1983, autism rates were 1 in 10,000 and
there were 11 vaccines in the pediatric schedule. Today there are 36
pediatric vaccines and autism rates are reported as high as 1 in 80 in local
school districts in Oregon and New Jersey.
The
US has the most bloated vaccine schedule
·The average of the top 30 countries is ½ of
our vaccine schedule (18 less vaccines).
Vaccines By Country sorted by number of vaccines
http://www.generationrescue.org/documents/SPECIAL%20REPORT%20AUTISM%202.pdf
In 1989, the vaccine makers
were given indemnity
Autism was 1 in 10,000 children and we only used 10
vaccines.
Almost all vaccines are approved for the US pediatric
schedule
The main bodies that makes the
recommended vaccine schedule is designed to rubber stamp vaccine requests.
- There are no individuals that specialize in
understanding the potential side effects of vaccines.
- There are no toxicological experts on the VRBPAC or
the ACIP.
- There are no chronic illness experts on the VRBPAC
or the ACIP.
- The VRBPAC and the ACIP (the two main
government body that determines the vaccine schedule) allows members to have
ties to the pharmaceutical companies.
Congress Has Found Significant Conflicts of Interest
in the VRBPAC and ACIP
Example: Quotes from the government investigation on
the Rotovirus vaccine
http://www.vaccineinfo.net/issues/conflictofinterest/ConflictsOfInterestHearing.shtml
“Staff Report Details FDA and CDC Conflicts in Approval of
Controversial Rotavirus Vaccine”
“A House Government Reform Committee staff report published
this week criticized the FDA and the CDC for routinely allowing scientists with
conflicts of interest to serve on two influential advisory committees that make
recommendations on vaccine policy.”
"It has become clear over the course of this
investigation that the VRBPAC and the ACIP [the two main advisory boards that
determine the vaccine schedule] are dominated by individuals with close working
relationships with the vaccine producers. This was never the intent of the
Federal Advisory Committee Act, which requires that a diversity of views be
represented on advisory committees."
ACIP Members with Conflicts of Interest Are Allowed On
the Board and Can Vote
“3. ACIP Members are allowed to Vote on Vaccine Recommendations,
Even When They Have Financial Ties to Drug Companies Developing Related or
Similar Vaccines”
Paul Offit, who has made more than 30 million dollars
on the Rotovirus Vaccine, voted his vaccine into the schedule three times.
“b. Dr. Paul Offit (Exhibits 38-41)”
“Dr. Offit shares the patent on the Rotavirus vaccine in
development by Merck and lists a $350,000 grant from Merck for Rotavirus
vaccine development. Also, he lists that he is a consultant to Merck. “
“Dr. Offit began his tenure on ACIP in October of
1998. Out of four votes pertaining to the ACIP’s rotavirus statement he
voted “yes” three times, including, voting for the inclusion of the rotavirus
vaccine in the VFC program.”
“Dr. Offit abstained from voting on the ACIP’s rescission of
the recommendation of the rotavirus vaccine for routine use. He stated at
the meeting, “I’m not conflicted with Wyeth, but because I consult with Merck
on the development of rotavirus vaccine, I would still prefer to abstain
because it creates a perception of conflict.”[lxvii]”
Rules about conflicts of interest are weak and lax.
Majority
Staff Report, Committee on Government Reform, U.S. House of Representatives
June 15, 2000
49 page report available at: http://www.generationrescue.org/pdf/3.5.pdf
A key quotation:
"Members of the advisory committees
are required to disclose any financial conflicts of interest and recuse
themselves from participating in decisions in which they have an interest. The
Committee’s investigation has determined that conflict of interest rules
employed by the FDA and the CDC have been weak, enforcement has been lax, and
committee members with substantial ties to pharmaceutical companies have been
given waivers to participate in committee proceedings."
Vaccines Can Cause Chronic Illness
Vaccination with the DTP vaccine on schedule led to
double the amount of asthma.
Delay in diphtheria, pertussis, tetanus vaccination is
associated with a reduced risk of childhood asthma.
McDonald KL, Huq SI, Lix LM, Becker AB, Kozyrskyj AL.
Faculty of Medicine, Department of Community Health
Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
BACKGROUND: Early childhood immunizations have been viewed
as promoters of asthma development by stimulating a T(H)2-type immune response
or decreasing microbial pressure, which shifts the balance between T(H)1 and
T(H)2 immunity. OBJECTIVE: Differing time schedules for childhood immunizations
may explain the discrepant findings of an association with asthma reported in
observational studies. This research was undertaken to determine whether timing
of diphtheria, pertussis, tetanus (DPT) immunization has an effect on the
development of childhood asthma by age 7 years. METHODS: This was a
retrospective longitudinal study of a cohort of children born in Manitoba in
1995. The complete immunization and health care records of cohort children from
birth until age 7 years were available for analysis. The adjusted odds ratio
for asthma at age 7 years according to timing of DPT immunization was computed
from multivariable logistic regression. RESULTS: Among 11, 531 children who
received at least 4 doses of DPT, the risk of asthma was reduced to (1/2) in
children whose first dose of DPT was delayed by more than 2 months. The
likelihood of asthma in children with delays in all 3 doses was 0.39 (95% CI,
0.18-0.86). CONCLUSION: We found a negative association between delay in
administration of the first dose of whole-cell DPT immunization in childhood
and the development of asthma; the association was greater with delays in all
of the first 3 doses. The mechanism for this phenomenon requires further
research.
http://www.ncbi.nlm.nih.gov/pubmed/18207561?ordinalpos=4&itool=...RVDocSum
Vaccinated children had more eczema, asthma hay fever
and food allergy
Reported pertussis infection and risk of atopy in 8- to
12-yr-old vaccinated and non-vaccinated children.
Bernsen RM, Nagelkerke NJ, Thijs C, van der Wouden JC.
Department of General Practice, Erasmus MC - University
Medical Center Rotterdam, Rotterdam, The Netherlands. roos.bernsen@uaeu.ac.ae
Pertussis infection has been suspected to be a potential
causal factor in the development of atopic disease because of the effect of
pertussis immunization on specific IgE antibodies. Although several studies
found a positive association between pertussis infection and atopic disorders,
this relationship has not yet been studied in a population stratified by
vaccination status. To assess the association between pertussis infection and
atopic disorders in pertussis-unvaccinated children and in pertussis-vaccinated
children. Using data from a previously conducted study on the relationship
between the diphtheria-tetanus-pertussis-(inactivated) poliomyelitis
vaccination in the first year of life and atopic disorders, the study
population of 1872 8-12 yr old was divided into children pertussis-unvaccinated
and children pertussis-vaccinated in the first year of life. Within each group,
the association between pertussis infection and atopic disorders (both as
reported by the parents) was assessed. In the unvaccinated group, there were no
significant associations between pertussis infection and atopic disorders. In
the vaccinated group, all associations between pertussis infection and atopic
disorders were positive, the associations with asthma [odds ratio (OR) = 2.24,
95% confidence interval (CI(95%)): 1.36-3.70], hay fever (OR = 2.35, CI(95%):
1.46-3.77) and food allergy (OR = 2.68, CI(95%): 1.48-4.85) being significant.
There was a positive association between pertussis infection and atopic
disorders in the pertussis vaccinated group only. From the present study, it
cannot be concluded whether this association is causal or due to reverse
causation.
HIB Vaccine can cause type 1 diabetes
Ann N Y Acad Sci. 2003 Nov;1005:404-8
Vaccinations may induce diabetes-related autoantibodies
in one-year-old children.
Wahlberg J, Fredriksson J, Vaarala O, Ludvigsson J; Abis
Study Group.
Division of Pediatrics, Department of
Molecular and Clinical Medicine, Faculty of Health Sciences, Linköping
University, Linköping, Sweden.
http://www.ncbi.nlm.nih.gov/pubmed/14679101?ordinalpos=10&itool=...RVDocSum
Vaccinations have been discussed as one
among many environmental candidates contributing to the immune process that
later may lead to type 1 diabetes. ABIS (All Babies in Southeast Sweden) is a
prospective cohort study following a nonselected birth cohort of general
population. In a randomly selected sample collection from 4400 children, GADA
and IA-2A have been determined at the age of 1 year. The information on
vaccinations was collected from questionnaires answered by the parents and was
related to beta cell autoantibodies. When studying the induction of
autoantibodies using the autoantibody level of 90th percentile as cutoff level,
hemophilus influenza B (HIB) vaccination appeared to be a risk factor for IA-2A
[OR 5.9 (CI 1.4-24.4; p = 0.01)] and for GADA [OR 3.4 (CI 1.1-10.8; p = 0.04)]
in logistic regression analyses. Furthermore, the titers of IA-2A were
significantly higher (p < 0.01 in Mann-Whitney test) in those children who
had got HIB vaccination. When 99th percentile was used as cutoff to identify
the children at risk of type 1 diabetes, BCG vaccination was associated with
increased prevalence of IA-2A (p < 0.01). We conclude that HIB
vaccination may have an unspecific stimulatory polyclonal effect increasing the
production of GADA and IA-2A. This might be of importance under circumstances
when the beta cell-related immune response is activated by other mechanisms.
PMID: 14679101
The U.S. Does Not Have Any Toxicologists or Chronic
Illness Experts on the VRBPAC or the ACIP
Although vaccines contain
neurotoxins and carcinogens, neither the VRBPAC or ACIP have any toxicologists
or chronic illness Experts on the committee.
http://www.cdc.gov/vaccines/recs/acip/members.htm
Advisory Committee on Immunization Practices
(ACIP)
Committee Membership Roster
January 21, 2009
CHAIRMAN
MORSE, Dale L., M.D.,
M.S.
Assistant Commissioner, Office of
Science
New York State Department of
Health
Albany, New
York
Term: 07/01/05-06/30/09
EXECUTIVE SECRETARY
PICKERING, Larry K., M.D.
Senior Advisor to the
Director
National Center for Immunization &
Respiratory
Diseases
Centers for Disease Control &
Prevention
1600 Clifton Road, NE, Mailstop
E-05
Atlanta, Georgia 30333
MEMBERS
BAKER, Carol,
M.D.
Professor of
Pediatrics
Molecular Virology and
Microbiology
Baylor College of
Medicine
Houston,
Texas
Term: 07/01/06-06/30/10
BECK, Robert L.,
J.D.
Consumer Representative
Palmyra,
Virginia
Term: 07/01/05-06/30/09
CHILTON, Lance,
M.D.
General Pediatrics and Adolescent Medicine,
Young Children's Health
Center
Professor, Department of
Pediatrics
University of New Mexico School of
Medicine
Albuquerque, New
Mexico
Term: 07/01/07-06/30/11
CIESLAK, Paul,
M.D.
Medical Director, Immunization Program
&
Program Manager, Acute & Communicable
Disease
Prevention
Oregon Public Health
Division
Portland,
Oregon
Term: 07/01/07-06/30/11
EHRESMANN, Kristen R.N., M.P.H.,
Section Chief
Immunization, Tuberculosis, and International
Health Section
Minnesota Department of Health
St. Paul,
Minnesota
Term: 07/01/2008 - 06/30/2012
ENGLUND, Janet,
M.D.
Associate Professor of Pediatrics, University
of
Washington
Clinical Associate, Fred Hutchinson Cancer
Research
Center
Division of Inf. Disease, Immunology and
Rheumatology
Children's Hospital and Regional Medical
Center
Seattle,
Washington
Term:
07/01/07-06/30/11
JUDSON, Franklyn N.,
M.D.
Professor, Departments of Medicine
(Infectious Diseases) & Preventive Medicine and Biometrics
University of Colorado Health Sciences Center
Denver,
Colorado
Term: 09/19/07-06/30/11
LETT, Susan M., M.D.,
M.P.H.
Medical Director, Immunization
Program
Division of Epidemiology and Immunization
Massachusetts Department of Public
Health
Jamaica Plain,
Massachusetts
Term: 07/01/06-06/30/10
MARCY, S. Michael, M.D.,
UCLA Center for Vaccine
Research
Harbor-UCLA Medical Center
Torrance,
California
Term: 07/01/2008 - 06/30/2012
MEISSNER, H. Cody, M.D.
Professor of Pediatrics
Tufts Medical Center
Boston, Massachusetts
Term: 07/01/2008 - 06/30/2012
NEUZIL, Kathleen, M.D.,
M.P.H.
Senior Clinical Advisor,
PATH
Clinical Associate Professor of Medicine,
University of
Washington
Seattle,
Washington
Term: 07/01/06-06/30/10
SAWYER, Mark H., M.D.
Professor of Clinical Pediatrics
Division of Pediatric Infectious Disease
UCSD School of Medicine and Rady Children's
Hospital San Diego
Medical Director, San Diego Immunization
Partnership
San Diego County HHSA Immunization Branch
San Diego, California
Term: 04/23/08-06/30/09
SUMAYA, Ciro Valent, M.D.,
M.P.H.T.M.
Founding Dean and Cox Endowed Chair in
Medicine
School of Rural Public
Health
Texas A&M Health Science
Center
College Station,
Texas
Term: 07/01/06-06/30/10
TEMTE, Jonathan, M.D. Ph.D.
Associate Professor
Department of Family Medicine
University of Wisconsin School of Medicine
and Public Health
Department of Family Medicine
Madison, Wisconsin
Term: 04/22/08-06/30/11
Ex Officio Members
Centers for Medicare and Medicaid Services
(CMS)
MURPHY,
Linda
CAPT,
USPHS
Senior Health Insurance
Specialist
Centers for Medicare & Medicaid
Services
Baltimore, Maryland
Department of Defense (DOD)
HACHEY, Wayne, DO,
M.P.H.
LTC, USA,
MC
Director, Preventive Medicine &
Surveillance
Office of the Assistant Secretary of Defense
Force Health Protection and
Readiness
Falls Church, Virginia
CIESLAK, Theodore (Ted),
M.D.
Col,
MC
Defense Department Liaison
Officer
Centers for Disease Control and
Prevention
Atlanta, Georgia
Department of Veterans Affairs (DVA)
Linda S. Kinsinger, MD, MPH
Chief Consultant for Preventive Medicine
Office of Patient Care Services
National Center for Health Promotion and
Disease Prevention
Durham, North Carolina
Food and Drug Administration (FDA)
BAYLOR, Norman,
Ph.D.
Director
Office of Vaccines Research
Review
Rockville, Maryland
(and
more)
This
document can be found on the CDC website at: http://www.cdc.gov/vaccines/recs/acip/downloads/members.pdf
Generation Rescue’s Independent California-Oregon
Vaccine Survey – More Autism, More ADHD, More Neurological Disorders
(link to full report) http://www.generationrescue.org/survey.html
Our Press Release here: http://www.generationrescue.org/survey_pr.html
A report from UPI here: http://www.generationrescue.org/olmstead.html
Congresswoman Carolyn Maloney (D-NY) - "Generation
Rescue's study is impressive and forcefully raises some serious questions about
the relationship between vaccines and autism. What is ultimately needed to
resolve this issue one way or the other is a comprehensive national study of
vaccinated and unvaccinated children," said Congresswoman Maloney.
"The parents, doctors and scientists behind Generation Rescue only want
information. They deserve more than road blocks, they deserve answers. We can
and should move forward in search of those answers. That's why I've introduced
a common sense bill that would require the National Institutes of Health (NIH)
to conduct a comprehensive, comparative study…”
Background
Generation Rescue commissioned an independent opinion
research firm, SurveyUSA of Verona NJ, to conduct a telephone survey in nine
counties in California and Oregon. Interviews were successfully completed in
11,817 households with one or more children age 4 to 17. From those 11,817
households, data on 17,674 children was gathered. Of the 17,674 children
inventoried, 991 were described as being completely unvaccinated. For each
unvaccinated child, a health battery was administered.
Generation Rescue chose to use telephone interviews with
parents to gather data on children, so as to closely mirror the methodology the
CDC uses to establish national prevalence for NDs such as ADHD and autism
through their national phone survey of parent responses. Generation Rescue
chose to focus on children ages 4-17 to match the age range used by CDC.
Are parent responses a reliable indicator of a child's
diagnostic status? According to Dr. Laura Schieve, co-author of the CDC's
national phone survey study, in discussing the CDC's two phone surveys on
autism prevalence, "the consistency of prevalence estimates across the two
surveys supports high reliability or reproducibility of parental report of
autism and reliability is one important component of validity."
SurveyUSA is a well-known national opinion research firm
with unique expertise in canvassing local communities. SurveyUSA has no vested
interest in any outcome this or any survey might produce. You can see a copy of
the questionnaire used in the survey here. The data the survey intended to
capture included:
- Households
with a child or children aged 4-17
- Whether
or not that child had been vaccinated
- Whether
or not that child had any one (or more) of the following diagnosis: ADD, ADHD,
Asperger's, PDD-NOS, Autism, Asthma, or Juvenile Diabetes (the final two of which
were added to consider other health outcomes).
The results of the survey allowed us to compare the
prevalence (what percentage of children have a particular diagnosis) to see if
there was any meaningful difference between unvaccinated and vaccinated children.
The most common way to measure prevalence differences is
through a calculation known as relative risk or the Risk Ratio, where we
compared prevalence amongst unvaccinated children to prevalence amongst
vaccinated children. So, if 5% of unvaccinated children have asthma, and 10% of
vaccinated children have asthma, that represents an "RR" of 2.0
(10%/5%), or a difference of 100%. We were also able to look at the data by
gender, age, and county.
Results
SurveyUSA gathered data on 9,175 boys and 8,499 girls
·
After thousands of reports of children
regressing into autism after receiving their childhood vaccines, Generation
Rescue conducted this independent survey of 17,674 children of which 991 were
unvaccinated.
·
Vaccinated individuals were reported to be :
a.
155% more likely to have neurological disorders
b.224% more likely to have ADHD
c.
61% more likely to have autism
·
To date, no one else has ever studied the
vaccinated and unvaccinated community looking for neurological outcomes.
Commentary
Generation Rescue is not representing that our study
definitively proves that the U.S. vaccine schedule has caused an epidemic in
neurological disorders amongst our children. That said, for less than $200,000,
we were able to complete a study that the CDC, with an $8 billion a year
budget, has been unable or unwilling to do. We think the results of our survey
lend credibility to the urgent need to do a larger scale study to compare
vaccinated and unvaccinated children for neurodevelopmental and chronic illness
outcomes.
They call our community Anti-Vaccine – It is not
true.
We are NOT anti-vaccine
a.
We ARE anti-schedule. We know our schedule is
too bloated and want to only vaccinate for the most serious diseases.
b. We want to go back to the 1983
schedule + HIB, since autism was 1 in 10,000 then, or use the Sweden,
Denmark , or Japan Vaccine schedule which also only use 11 vaccines and
those countries have a much lower under 5 year old mortality rate.
2.) We ARE anti-toxin.
a.
Most of the 35 vaccines ingredients do not have
positive safety studies.
b.
We are concerned about the Aluminum, formaldehyde,
MSG, diseased monkey cells, mercury and other ingredients that are toxins and
have not been properly safety tested.
Aluminum
1.
Through extensive scientific study, has been shown
to be neurotoxin (kills brain cells), is linked to Alzheimer’s, and cancer.
2.
There are 19 Studies About Aluminum Toxicity on our
website at: http://www.generationrescue.org/autism/08-aluminum-toxicity.htm
3.
Aluminum is delivered at a very high rate in
vaccines and is above EPA levels for adults during any typical pediatric
vaccine visit and above safety levels just by vaccination with the DTaP or MMR
vaccines.
Calculating Aluminum in Vaccines
Here are the current levels of aluminum per shot of the
following vaccines, as listed on the packaging of each vaccine:
* HIB - PedVax – 225 mcg Aluminum
* PC (Pneumococcal) Vaccine – 125 mcg
Aluminum
* DTaP – Taptacel Brand (Sanofi Pasteur)
– 330 mcg Aluminum
* DTaP – Tripedia Brand (Sanofi Pasteur)
– 170 mcg Aluminum
* DTap – Infanrix Brand (GlaxoSMithKline)
– 625 mcg Aluminum
* DT (Sanofi Pasteur) – 170 mcg Aluminum
* dT – Decavac (Sanofi Pasteur) – 280 mcg
Aluminum
* Heb P – Recombivax (Merck) – 250 mcg
Aluminum
* Hep B – Engerix-B (GlaxoSMithKline) –
250 mcg Aluminum
* Hepatitis A – 250 mcg Aluminum
* HPV – Gardasil – 225 mcg Aluminum
Combination Vaccines
* Comvax (hep B and HIB) – 225 mcg
Aluminum
* Pentacel (DTaP, HIB and Polio) – 330
mcg Aluminum
In other words, a newborn who gets a Hepatitis B injection
on day one of life would receive 250 mcg of aluminum. This would be repeated at
one month with the next Hep B shot. When, at two months, a baby gets its first
big round of shots, the total dose of aluminum could vary from 295 mcg (if a
non-aluminum HIB and the lowest-aluminum brand of DTaP are used) to a whopping
1225 mcg (if the Hep B vaccine is given along with the brands with the highest
aluminum contents). These doses are repeated at four and six months. With most
subsequent rounds of shots, a child would continue to get some aluminum
throughout the first two years. But the FDA recommends that premature babies,
and anyone with impaired kidney function, receive no more than 10 to 25 mcg of
injected aluminum at any one time.
Sources: Dr. David Ayoub and The Vaccine Book by Dr. Bob Sears
Formaldehyde
is a cancer-causing
agent and is in most vaccines.
Mercury
is still in several flu
vaccines (25 mcg of mercury) and several other vaccines in trace amounts.
Trace amounts are above the toxic standards for water.
The EPA recommended daily exposure: .4 mcg http://www.epa.gov/teach/chem_summ/mercury_org_summary.pdf
Vaccines are not safety tested for cancer or DNA
altering effects (mutanegenic effects), even though they have cancer-causing
(carcinogenic) ingredients and mutated viruses in them.
1.) Most
Manufacturer Vaccine Information Sheets (VIS) Say, “[vaccine name]
vaccine has not been evaluated for carcinogenic [cancer causing] or mutanegenic
[DNA altering] potential or impairment of fertility”
a.
Studies show that heavy metals can trigger
life-long chronic illness.
“Epigenetic
fetal programming via DNA methylation may provide a pathway by which
environmental lead exposure can influence disease susceptibility.”
http://www.ehponline.org/members/2009/0800497/0800497.pdf
b.
A summary of vaccine ingredients, side effects and
evidence of lack of safety testing is available at. www.GenerationRescue.org/vaccine_information/
|
